Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer
暂无分享,去创建一个
M. Ehrlich | E. Fiala | C. Rodríguez | C. Grunau | L. Dubeau | S. Krieger | P. van der Bruggen | W. Hindermann | A. De Sario | Cecilia G. Sanchez
[1] Hansoo Lee,et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. , 2003, Biochemical and biophysical research communications.
[2] M. Ventura,et al. Juxtacentromeric region of human chromosome 21: a boundary between centromeric heterochromatin and euchromatic chromosome arms. , 2003, Gene.
[3] Masatoshi Watanabe,et al. Aberrant methylation of the vascular endothelial growth factor receptor‐1 gene in prostate cancer , 2003, Cancer science.
[4] M. Ehrlich,et al. Expression of various genes is controlled by DNA methylation during mammalian development , 2003, Journal of cellular biochemistry.
[5] P. Laird. Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.
[6] G. V. van Muijen,et al. Cancer/testis‐associated genes: Identification, expression profile, and putative function , 2003, Journal of cellular physiology.
[7] Christian B. Woods,et al. Satellite DNA hypomethylation in karyotyped Wilms tumors. , 2003, Cancer genetics and cytogenetics.
[8] Edison T Liu,et al. Classification of cancers by expression profiling. , 2003, Current opinion in genetics & development.
[9] Daiya Takai,et al. The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..
[10] S. Boyle,et al. New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile , 2002, European Journal of Human Genetics.
[11] P. Laird,et al. Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.
[12] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[13] M. Esteller. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.
[14] I. Ruschenburg,et al. mRNA detection of tumor‐rejection genes BAGE, GAGE, and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool , 2002, Cancer.
[15] D. Jäger,et al. Clinical cancer vaccine trials. , 2002, Current opinion in immunology.
[16] R. Ferrini. Screening for skin cancer. , 2002, American family physician.
[17] P. Dalerba,et al. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas , 2001, International journal of cancer.
[18] Christoph Grunau,et al. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters , 2001, Nucleic Acids Res..
[19] M. Helfand,et al. Screening for skin cancer. , 2001, American journal of preventive medicine.
[20] H Ishii,et al. Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.
[21] F. Buntinx,et al. Rectal bleeding and colorectal cancer in general practice: diagnostic study , 2000, BMJ : British Medical Journal.
[22] K. Nouso,et al. Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma. , 2000, Journal of hepatology.
[23] A. Rosenthal,et al. MethTools--a toolbox to visualize and analyze DNA methylation data. , 2000, Nucleic acids research.
[24] Thierry Boon,et al. DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter , 1999, Molecular and Cellular Biology.
[25] M. Ehrlich,et al. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.
[26] M. Ehrlich,et al. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.
[27] W. Catalona,et al. Racial differences in operating characteristics of prostate cancer screening tests. , 1997, The Journal of urology.
[28] P. Laird,et al. COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.
[29] K. Sugimachi,et al. Expression of MAGE and BAGE genes in Japanese breast cancers. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] Graham R. Taylor,et al. Laboratory Methods for the Detection of Mutations and Polymorphisms in DNA , 1997 .
[31] M. Mori,et al. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] D. S. Prestridge. Predicting Pol II promoter sequences using transcription factor binding sites. , 1995, Journal of molecular biology.
[33] R. Brasseur,et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. , 1995, Immunity.
[34] André Rosenthal,et al. Large-scale production of DNA sequencing templates by microtitre format PCR , 1993, Nucleic Acids Res..
[35] L. E. McDonald,et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Tennant,et al. Rectal bleeding , 1990 .
[37] M. Ehrlich,et al. Hypermethylation of human DNA sequences in embryonal carcinoma cells and somatic tissues but not in sperm. , 1987, Nucleic acids research.
[38] X. Y. Zhang,et al. Human DNA sequences exhibiting gamete-specific hypomethylation , 1985, Nucleic Acids Res..
[39] D. Wolgemuth,et al. Methylation of satellite sequences in mouse spermatogenic and somatic DNAs. , 1984, Nucleic acids research.
[40] L. S. Minckler. Racial Differences , 1924, Science.